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Abstract
To search for clues suggesting that beta cells may generate by transdifferentiation in
humans, we assessed the presence of cells double positive for exocrine (amylase, carboxy-
peptidase A) and endocrine (insulin) markers in the pancreas of non-diabetic individuals
(ND) and patients with type 2 diabetes (T2D). Samples from twelve ND and twelve matched
T2D multiorgan donors were studied by electron microscopy, including amylase and insulin
immunogold labeling; carboxypeptidase A immunofluorescence light microscopy assess-
ment was also performed. In the pancreas from four T2D donors, cells containing both
zymogen-like and insulin-like granules were observed, scattered in the exocrine compart-
ment. Nature of granules was confirmed by immunogold labeling for amylase and insulin.
Double positive cells ranged from 0.82 to 1.74 per mm2, corresponding to 0.26±0.045% of
the counted exocrine cells. Intriguingly, cells of the innate immune systems (mast cells and/
or macrophages) were adjacent to 33.3±13.6% of these hybrid cells. No cells showing co-
localization of amylase and insulin were found in ND samples by electron microscopy. Simi-
larly, cells containing both carboxypeptidase A and insulin were more frequently observed in
the diabetic pancreata. These results demonstrate more abundant presence of cells con-
taining both acinar markers and insulin in the pancreas of T2D subjects, which suggests
possible conversion from one cellular type to the other and specific association with the dis-
eased condition.
Introduction
Type 2 diabetes (T2D) is characterized by defects of beta cell mass and function [1]. Although
possibly overestimated [2], the loss of beta cell mass is likely due to increased apoptosis and
other forms of cell death, associated with inadequate regeneration [1,3]. Nevertheless, some
studies have suggested increased beta cell neogenesis (formation of new beta cells from
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precursors) in human T2D, obesity and pregnancy (reviewed in [3]). One possibility is that
beta cells may generate through transdifferentation (i.e. conversion from a different, fully dif-
ferentiated cell type) from endocrine and non-endocrine pancreatic cells [1,4–6]. Genetic line-
age tracing experiments to determine the origin of new beta cells [7–9] can not be performed
in the human setting. However, observational studies with the pancreas of non-diabetic and
T2D subjects show the presence of endocrine cells containing both glucagon and insulin gran-
ules [10–12], which may be interpreted as the conversion of some beta to alpha cells or vice
versa, as more clearly demonstrated in rodent models [13,14]. In addition, anecdoctal evidence
has been previously reported of the presence of single cells in the pancreas of one healthy sub-
ject, containing zymogen granules and a few granules resembling the insulin ones [15]. Simi-
larly, acinar cells with also glucagon granules have been described in two individuals with type
1 diabetes [16]. In agreement with these latter findings, work from a few laboratories has dem-
onstrated ex vivo formation of beta cell like cells from human acinar tissue by the use of differ-
ent experimental approaches [17,18]. However, clues are missing on whether this may be the
case in vivo in the human T2D condition. In the present study we performed ultrastructural
and immunocytochemistry evaluations of pancreatic samples from 12 non-diabetic (ND) and
12 matched T2D multiorgan donors to show the presence of cells containing both acinar cell
markers and insulin, that were more frequent in the pancreas of subjects with T2D, suggesting
that transition from one cell type to the other could occur in vivo.
Methods
Pancreatic samples from 24 multiorgan donors (12 ND: age, 65.0±3.05 years; BMI, 27.3±0.99
kg/m2; and 12 matched T2D: age, 69.0±2.55 years; BMI, 27.2±0.97 kg/m2) were obtained with
informed written consent and processed according to the procedures previously detailed
[19,20], with the approval of the local ethics committee of the Pisa University. Causes of death
were similar in both donor groups: trauma, two and three in the ND and T2D group respec-
tively; cardiovascular events, ten and nine. Pancreas cold ischaemia time was<18 h in both
groups. In the diabetic group, known duration of the disease was 12.3±2.5 years and all the
patients were anti-GAD autoantibody negative. Three patients with diabetes were treated with
metformin alone, one with a sulphonylurea alone, five with combined sulphonylurea and met-
formin, and two with insulin therapy.
Electron microscopy studies were performed as previously described [21,22], with pancre-
atic samples taken in all the cases at the level of the neck of the gland (before accomplishment
of islet isolation, as done routinely in our unit with pancreata not suitable for whole organ
transplantation). Non-endocrine and endocrine cells were identified based on their ultrastruc-
tural appearance, including the presence of the respective, typical secretory granules [21,22].
Double immunogold labeling for amylase and insulin was performed according to Bendayan
[23] by the use of guinea pig anti-insulin and rabbit anti-human α-amylase antibodies (Sigma
Aldrich, St. Louis, MO, USA), together with protein A conjugated gold particles (Agar Scien-
tific, Stansted, UK), sized 15 nm for insulin and 5 nm for amylase. For each pancreas, 4 tissue
blocks and 33–36 non-consecutive ultra-thin sections were analyzed. Cells of the immune sys-
tem (macrophages, lymphocytes and mastcells) were classified according to their peculiar elec-
tron microscopy characteristics, as previously described by us and others [22,24–26].
Immunofluorescence studies were performed as described [27]. Briefly, pancreatic paraffin
sections were immunostained with polyclonal guinea pig anti-insulin (1/3000, gift from prof.
C. Van Schravendijk, Brussels), and rabbit anti-carboxypeptidase A (1/1000, AbD Serotec
1810–0006, Oxford, UK). Secondary antibodies were FITC-labeled donkey anti-guinea pig
and Alexa Fluor 594-labeled donkey anti-rabbit diluted 1/200 (Jackson Immuno Research,
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West Grove, USA). Negative controls consisted in omitting the primary antibody. Immunoflu-
orescence was analyzed with a Zeiss LSM710 confocal microscope (Carl Zeiss, Jena,
Germany).
Data are expressed as mean±SEM and the two-tailed Student’s t-test was used for statistical
comparison of the results.
Results
The pancreatic area that was examined by electron microscopy was 2.67±0.35 and 2.76±0.47
mm2 for ND and type 2 diabetes samples, respectively. Semithin sections were first prepared
to localize islets and endocrine cell clusters (Fig 1A and 1B), which were then analyzed by elec-
tron microscopy (Fig 1C and 1D, Figs 2 and 3). In sections of pancreatic tissue from 4 out of
Fig 1. Representative semithin and electron microscopy images of pancreatic cells in T2D slides. A: Semithin section
(stained with a 1:1 mixture of toluidine blue, 1% in bidistilled water, and methylen blue, 1% in bidistilled water) showing a cluster of 4
cells with islet-like appearance (magnification: 1,000x), enlarged in B (N: nucleus); C and D: Electron microscopy of cells containing
both zymogen-like (black arrows) and insulin-like (white arrows) granules (magnification: 10,000x). ER in D indicates the
endoplasmic reticulum, looking expanded and convoluted in this specific T2D beta cell.
https://doi.org/10.1371/journal.pone.0179398.g001
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the total 12 T2D donors (but in none of those from ND subjects), and within small clusters of
cells with islet-like appearance scattered in the acinar tissue, a few cells were observed, contain-
ing both zymogen-like and insulin-like granules in their cytoplasm (Fig 1C and 1D, Figs 2 and
3). By this electron microscopy approach, no cell within the islets (29 islets examined, 5,655
endocrine cells analyzed) was found to contain both zymogen- and insulin-like granules.
When the immunogold technique was applied with the simultaneous utilization of anti-amy-
lase and anti-insulin antibodies together with protein A conjugated gold particles of different
size (5 and 15 nm, respectively), the zymogen-like granules were labeled for amylase whereas
the insulin-like granules were indeed positive for insulin (Figs 4 and 5). Overall, 8,113 (range:
1,123–3,257) acinar cells were counted in these four T2D cases, of which 20 (range: 3–9 per
case) contained both types of granules (corresponding to 0.26±0.045% of acinar cells, range:
0.15 to 0.37%). When normalized to the pancreatic areas analyzed, the hybrid cells were 1.34
±0.23 per mm2 (range: 0.82–1.74). To implement the electron microscopy findings, paraffin
sections from the pancreas of 6 ND and 7 T2D donors were also analyzed immunohistochemi-
cally by confocal microscopy for the expression of insulin and the exocrine acinar cell marker
carboxypeptidase-A. With this approach, cells positive for both carboxypeptidase-A and insu-
lin were commonly found both in endocrine clusters and, more frequently so, within the islets
Fig 2. Electron microscopy images (magnification 10,000x) of pancreatic cells containing both zymogen-like (black arrows) and
insulin-like (white arrows) granules in the four cases with T2D.
https://doi.org/10.1371/journal.pone.0179398.g002
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(Fig 6, S1 and S2 Figs). Overall, 27.3±2.7 clusters and islets were examined per pancreas, and
cells containing both proteins were 3–4 fold more numerous in the T2D (74.9±2.5% of the
analyzed structures) than the ND (22.5±9.3%) samples (p<0.01).
Intriguingly, by electron microscopy cells of the immune system (mainly mast cells and/or
macrophages, more rarely lymphocytes) adjacent to the cells containing zymogen and insulin
granules were observed in 33.3±13.6% (range: 0–66.6%) of cases. More precisely, mast cells
were seen in 19.4±8.4% and macrophage in 13.9±8.3% of cases. Usually, the ratio of hybrid
cells to immune system cells was 1:1; however, in one case, 3 cells of the immune system were
identified close to 1 mixed cell (Fig 7). Occasional single beta cells (0.23±0.17 per mm2) were
also observed scattered in the acinar tissue (S3 Fig); however, none of these single beta cells
was seen with adjacent cells of immune system.
The subgroup of T2D donors showing pancreatic cells double positive for acinar and endo-
crine (insulin) markers at the electron microscopy analyses had similar age (70±2.9 vs 67.6
±3.27 yrs), BMI (26.7±0.48 vs 27.5±1.2 kg/m2) and known duration of diabetes (14.2±5.5 vs
11.1±2.2 yrs) as the subgroup of T2D individuals in whom this type of cells was not observed.
In addition, average plasma glucose values during the period of intensive care unit stay were
Fig 3. Electron microscopy images (A and B, magnification 10,000x, with squares enlarged in a and b, respectively) showing
pancreatic cells in T2D samples, containing both zymogen-like (black arrows) and insulin-like (white arrows) granules, and with
cell membrane indicated by the dotted black arrows.
https://doi.org/10.1371/journal.pone.0179398.g003
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also similar in the two series: 10.4±1.2 vs 11.7±1.0 mmol/L (187±22 vs 210±18 mg/dl). The
antidiabetic therapy of the four T2D subjects with double positive cells was metformin alone
(1 case), sulphonylurea alone (1 case) or metformin plus sulphonylurea (2 cases).
Discussion
By performing electron microscopy and immunofluorescence studies, this report shows for
the first time that cells double positive for markers of acinar cells and insulin can be found in
the human pancreas, with increased abundance in T2D individuals. The presence of cells with
both exocrine and endocrine granules as observed by electron microscopy was first described
in animal models [28]. Successively, evidence has been reported of single cells in the pancreas
of one healthy subject, containing both zymogen and insulin resembling granules [15], and of
acinar cells in two individuals with type 1 diabetes with also glucagon granules [16]. Here we
report co-localization of zymogen- and insulin granules in pancreatic cells of a subgroup of
T2D subjects. These cells were found in small endocrine clusters scattered in the acinar tissue,
but not in the islets. Although limited to a small portion of the pancreatic gland, the electron
microscopy results of the present study indicate that the quantity of these hybrid cells (appoxi-
mately 0.25% of acinar cells) could not be negligible, considering that, in humans, beta cell
mass is approximately 1–2% of the total pancreatic mass [1,3,29,30]. It can not be excluded
that in other parts of the pancreas (such as the tail portion, where some studies have reported
the presence of an increased amount of islets [31]) these figures can be different. In addition,
when the presence of carboxypeptidase A was also investigated by immunofluorescence tech-
niques, we found that the amount of cells co-expressing this acinar tissue marker [32,33] and
Fig 4. Immunogold labeling of amylase (particle size: 5 nm) and/or insulin (particle size: 15 nm) in an acinar cell (A, square
enlarged in a, showing only amylase particles), a beta cell (B, square enlarged in b, showing only insulin particles), and a hybrid
cell (C, square enlarged in c, showing both amylase and insulin particles) in a T2D sample. A, B and C: magnification 38,000x; the
cell membrane is indicated by the dotted black arrows. Lymph indicates a lymphocyte close to the hybrid cell (see also Fig 7 for additional
images of cells of the immune system).
https://doi.org/10.1371/journal.pone.0179398.g004
Acinar markers and insulin in pancreatic cells
PLOS ONE | https://doi.org/10.1371/journal.pone.0179398 June 15, 2017 6 / 12
insulin was significantly higher in T2D sample as well. Interestingly, carboxypeptidase A is
upregulated in islet beta cells from T2D patients obtained by laser capture microdissection,
compared to non-diabetic controls [34], and it is expressed in insulin producing cells derived
from embryonic stem cells [35].
Unexpectedly, our observation identified cells of the immune system (mainly mast cells and
macrophages) adjacent to the majority of the cells positive for both acinar and insulin granules.
Increased immune cell infiltration of pancreatic islets is considered a marker of inflammation,
associated with beta cell functional and survival alterations in type 2 diabetes [21,36,37]. How-
ever, depending on features of the infiltrating cells and expressed cytokines, “inflammation”
may also have beneficial action, including a contribution to pancreas development and cell
repair/regeneration [38–40].
Therefore, although indirectly, our findings suggest that under certain circumstances beta
cells may derive from pancreatic acinar cells by transdifferentiation, potentially leading to beta
cell regeneration in the human pancreas. Transdifferentiation phenomena have been well
described and clearly demonstrated in experimental models [5,6,9,14,41–43], and work ex vivo
with human acinar cells have suggested the feasibility of reprogramming pancreatic non-
Fig 5. Immunogold labeling of amylase (particle size: 5 nm) and insulin (particle size: 15 nm) of an hybrid cell (magnification:
38,000x) in T2D samples, showing different cellular areas (numbered squares are enlarged) with both positivities in the
cytoplasm.
https://doi.org/10.1371/journal.pone.0179398.g005
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endocrine cells toward an insulin producing cell phenotype [17,18]. The molecular mecha-
nisms associated with the reprogramming of human acinar cells to insulin containing cells are
not fully clear, but previous work in murine models by viral transduction has shown that neu-
rogenin 3, PDX-1 and MafA are likely to play key roles [41,42]. In addition, in their recent ex
vivo experiments, Lemper et al used lentiviruses expressing activated mitogen-activated pro-
tein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) to redirect
human acinar cells to beta cell like products [17]. Alternatively, Klein et al used exposure to
bone morphogenetic protein 7 (BMP7) to induce conversion of non-endocrine cells to insulin
producing cells [18]. These experiments were conducted with tissue derived from non-diabetic
donors, and it remains to be assessed if these or other mechanisms may be involved in the in
vivo diabetic human situation.
Intriguingly, we found more cells containing both amylase and insulin, or both carboxypep-
tidase A and insulin, in T2D than ND pancreatic samples. These differences may reflect bio-
logical diversities. For instance, it has been reported that a “neogenic” index calculated on the
number of insulin positive cells/clusters was significantly higher in subgroups of type 2 dia-
betic than in ND organ donors [29]. In addition, our electron microscopy results showed that
1/3 of type 2 diabetic pancreatic samples showed cells with both amylase and insulin. This
Fig 6. Confocal microscopy images of double immunohistochemical stainings for insulin (green), the
acinar enzyme carboxypeptidase A (red) or both the markers (yellow in merge panels). Blue staining is
DNA (DAPI, Hoechst dye. Representative cells are shown from a control non-diabetic subject (left panels) and
from a subject with type 2 diabetes (right panel).
https://doi.org/10.1371/journal.pone.0179398.g006
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does not seem to be due to differences in the main clinical features of the T2D donors (age,
gender, BMI, known duration of diabetes, blood glucose values during the ICU stay), nor to
the type of anti-diabetic therapy at time of death. One possibility is that blood glucose control
over a longer period of time (an information not available in our study) may have played a
role. For instance, insulin positive area has been reported to correlate negatively with HbA1c
levels in donors at the time of death [44].
In conclusion, our results indicate that in subjects with type 2 diabetes more pancreatic
cells possess features of both the acinar and beta cell phenotype, in comparison with non-dia-
betic controls, suggesting previously unseen elements of in vivo pancreatic cell plasticity in
humans, that may contribute to beta cell neogenesis. However, our observations can not rule
out the possibility that, conversely, beta cells may transdifferentiate into acinar cells. Whether
our present findings may be applied to other forms of diabetes, including type 1 diabetes, and
if the possibility exists that cells positive for acinar markers and insulin could be differently tar-
geted by the immune system, remain currently unknown.
Fig 7. Representative image (left panel) of a pancreatic cell in T2D samples containing both amylase (black arrows) and insulin
(white arrows) granules, with adjacent cells of the immune system. The image has been reconstructed from several pictures at
10,000x final magnification. Enlargments are provided in the right panels. Mc: macrophage, Lymph: lymphocyte, Ms: mast cell.
https://doi.org/10.1371/journal.pone.0179398.g007
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